DEVELOPMENT AND VALIDATION OF A PROCEDURE FOR ASSAY OF A NEW SUBSTANCE


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Introduction. The Volgograd State Medical University synthesized a new substance from the class of acetanilide derivatives of quinazolin-4(3H)-one (Laboratory Code VMA-10-1). The results of a preliminary pharmacological assay showed that this compound is characterized by an original spectrum of psychotropic activity. The substance has weak basic properties and is very slightly soluble in water; it is advisable to use an acid-base titration assay in the non-aqueous media for quantification of the substance. Objective: to develop and validate a procedure for assay of the new substance VMA-10-18. Material and methods. The investigation object was the standard sample of the new substance VMA-10-18. Class A volumetric glassware was used in the investigation. The investigators employed formic acid, acetic acid, and acetic anhydride as solvents, 0.1 M perchloric acid as a titrant, and 0.1% crystal violet solution as an indicator. The procedure was validated in accordance with the requirements of the 14th edition of the State Pharmacopoeia of the Russian Federation. Results. The optimal conditions were established for the titrimetric analysis of the substance derived from quinazolin-4(3H)-one. The analytical procedure was validated in terms of specificity, linearity, analytical area, precision, and accuracy. Conclusion. The developed procedure for assaying the new substance, a quinazolin-4(3H)-one derivative, is valid and can be used in quality control.

全文:

受限制的访问

作者简介

Ekaterina Mishchenko

Pyatigorsk Medical and Pharmaceutical Institute, Branch, Volgograd State Medical University

Email: ekaterina-mischenko1809@mail.ru
a graduate student of the Department of Pharmaceutical and Toxicological Chemistry 11, Kalinin Pr., Pyatigorsk 357532, Russian Federation

John Lazaryan

Pyatigorsk Medical and Pharmaceutical Institute, Branch, Volgograd State Medical University

Email: j.s.lazaryan@pmedpharm.ru
Head of the Department of Pharmaceutical and Toxicological Chemistry, Doctor of Pharmaceutical Sciences, Professor. 11, Kalinin Pr., Pyatigorsk 357532, Russian Federation

Alexander Ozerov

Volgograd State Medical University

Email: prof_ozerov@yahoo.com
Head of the Department of Pharmaceutical and Toxicological Chemistry, Doctor of Chemical Sciences, Professor 1, Pavshikh Bortsov St., Volgograd 400131, Russian Federation

参考

  1. Петров В.И., Тюренков И.Н., Озеров А.А. Производные хинолизидина, обладающие антидепрессивной, анксиолитической и ноотропной активностью. Патент РФ № 2507199. Бюллетень № 5, 2014: 12.
  2. Цибизова А.А., Самотруева М.А., Ковалев В.Б., Тюренков И.Н. Фармакологическая активность производных бензодиазина. Астраханский медицинский журнал,201 7; 4: 27-43.
  3. Михайлов В.А., Дружинин А.К., Шова Н.И. Аффективные постинсультные расстройства: патогенез, диагностика, лечение. Обозрение психиатрии и медицинской психологии, 2018; 1: 115-9.
  4. Тюренков И.Н., Озеров А.А., Шматова Е.Н., Арчакова Ю.В. Ноотропная активность амидов хиназолинового ряда. Химико-фармацевтический журнал, 2015; 49 (2): 18-20.
  5. Alajbegovic A., DjeLiLovic-Vranic J., Alajbegovic S. PostStroke Depression. Med.Arch., 2014; vol. 68: 47-50.
  6. Берлянд А.С., Ковалева Е.Л., Шаназаров К.С. Пути совершенствования и новые подходы к стандартизации фармацевтических субстанций. Фармацевтический анализ. Серия «Проблемы аналитической химии. Отделение химии и наук о материалах РАН». Под ред. Г.К, Будникова, С.Ю. Гармонова. М.: 2013; 23-66.
  7. Государственная Фармакопея Российской Федерации. XIV изд. Т. 1. М., 2015. [Электронное издание]. Режим доступа: http://femb.ru/feml
  8. Guidelines for standard method performance requirements. Access mode: http://aoac.org/imis15_prod/AOAC_Docs/ StandardsDevelopment/eoma_appendix_f.pdf.

补充文件

附件文件
动作
1. JATS XML
##common.cookie##